Navigation Links
Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
Date:11/13/2007

of the webcast will be available on Isis' web site for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing drugs for a wide variety of diseases. Ibis Biosciences, Inc., Isis' wholly owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding the development, activity, therapeutic potential and safety of mipomersen in treating patients with high cholesterol. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

7

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/--CempraPharmaceuticalsInc.todayannouncedt...officer,willpresentatthePiperJaffray21stAnnualHeal...NewYorkPalaceHotelinNewYorkCity.Dr.Fernandeswillpr...linicalprogramsforthetreatmentofdrug-resistantpath...als ,, Foundedin2006,CempraPharmaceuticalsisap...
(Date:11/25/2009)...ANNESBURG,November25/PRNewswire/--,iThembaPharmace...oday,thattheyhavesignedacollaborativeagreementtojo...worldclasscomputationalchemistryandleaddiscoveryex...oprovidemedicinaland,syntheticchemistrysupporttopr...etwork.iThembaPharmaceuticalsandPyxisDiscovery,als...
(Date:11/24/2009)...wire-Asia/--ChindexInternational,Inc.,("Chindex")(...ofWestern,healthcareproductsandservicesinthePeople...lattendthe21stAnnualPiperJaffray,"Unplugged"Health...orkPalaceHotel. , Managementiscurrentlyschedu...ndholdone-on-onemeetingsthroughouttheday.Awebcast,...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2Weight Loss Surgery Options Compared in Super Obese 47682 1Weight Loss Surgery Options Compared in Super Obese 47682 2Heart Drug Combos Raise Risk of Gastrointestinal Bleeding 47680 1Heart Drug Combos Raise Risk of Gastrointestinal Bleeding 47680 2Governor Rendell Proposes Offering Prescription Help to 30 000 More Older Adults as Part of Plan to Save 2460 Million 47678 1Governor Rendell Proposes Offering Prescription Help to 30 000 More Older Adults as Part of Plan to Save 2460 Million 47678 2
...fic Conference -, ORLANDO, Fla., Oct. 6 Ironwood...ed presentation of data from a pair of,preclinical...e,monophosphate (cGMP) plays in alleviating intest...ibits intestinal pain in a preclinical model of,in...erent nerves in a,similar model of experimental co...
...Therapy is More Likely to Induce Steroid-Free Re... Immunomodulator, Azathioprine...irst time,from the Phase 3b Study of Patients with...logic Therapy (SONIC) may provide new insights int...o severe Crohn,s disease.,According to findings fr...
Other Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8
(Date:11/25/2009)... Adam DreamHealer’s Glo...aling intentions changes the physiology of someone...ing intentions at a time unknown to a volunteer wh...s analyzed by world experts in the USA and Canada....November 25, 2009 -- Adam DreamHealer’s Gl...
(Date:11/25/2009)... The American Society of Hema...squo;s publishing, education, and media company, a...rdquo; a dynamic science curriculum designed to sp..., in addition to exposing students to exciting car... Washington (PRWEB) November 25, 2009 -- ...
(Date:11/25/2009)... The Oklahoma Thunder basketb...st-class concepts in nutrition, hydrotherapy, tech...he new Integris Health Thunder Development Center....organization made the obvious choice for aquatic t...ols from industry leader, HydroWorx. The HydroWorx...
(Date:11/25/2009)..., VANCOUVER,Nov.25/PRNewswire/-- AdamDreamHealer...lingintentionschangesthephysiologyofsomeoneatadist...atimeunknowntoavolunteerwhowasmonitoredbyaquantita...ndCanada. ,, OnNovember8inVancouver,B.C.Adamini...t.Tofocusintentions,Adamcreatedavideoclipofaspecif...
(Date:11/24/2009)...-call radiology residents generally provide accura...diology CT scans after hours when attending neuror...large study performed at a level I trauma center p...the American College of Radiology ( JACR ). , ...ssential element of diagnostic radiology. In most ...
Breaking Medicine News(10 mins):Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Oklahoma Thunder Inserts HydroWorx into Line-Up at Integris Health Center 2Health News:Oklahoma Thunder Inserts HydroWorx into Line-Up at Integris Health Center 3Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2
...ng Plan Improves Access, Modernizes Technology , ...posed budget for the Department of Veterans Affair...dditional 500,000 deserving Veterans over the next...lity health care for the Nation,s 5.5 million Vete...
...nnovative mentoring program at the UCSF-Gladstone ...IDS Research is providing vital support for the de...rchers and clinician scientists. , Described in...uses on overcoming challenges faced by early-caree...
...SBURG, Pa., Feb. 26 Dean Farms in New Castle, Law...er contamination and resumed sales of raw milk on...s Wolff said today. , , Raw milk is milk that ha... associated with consuming the unpasteurized produ...
...NGTON, Feb, 26 The following is a statement from ...e Director of the American Public Health Associati...APHA) joins other leading health organizations, me...d emphasis on prevention, the inclusion of health ...
...NGTON, Feb. 26 The Susan G. Komen for the Cure(R)... for laying the groundwork for fundamental health ...and delivering the cures to cancer with the releas...o hear President Obama voice his commitment to ref...
...ONVILLE, Fla. Feb. 26 First Coast Service Options...ce Medicare administrators, announced today that i...ase of a new Medicare administrative contract the ...dicare Part A and B administrative services for Pu...
Other Medicine News:Health News:President's 2010 Budget Request Strongly Supports VA Programs 2Health News:Effective mentoring critical to HIV/AIDS research efforts 2Health News:Lawrence County Raw Milk Dairy Tests Negative For Campylobacter; Raw Milk Sales Resumed 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Obama for Commitment to Health Reform, Cancer Research, in Budget Blueprint 2Health News:First Coast Service Options Announces Start-up of New Medicare Contract in Puerto Rico 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: